Results 171 to 180 of about 41,822 (262)

Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16− Patients Affected by Oropharyngeal Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Oropharyngeal cancer (OPC) exhibits distinct clinical behaviors according to HPV/p16 status and smoking exposure. While HPV‐positive OPC generally shows superior survival, differences in recurrence patterns remain unclear. Methods A retrospective multicenter analysis of 674 AJCC VII edition Stage III–IVa/b OPC patients treated with ...
Riccardo Gili, Paolo Bossi, Luca Lalli, Lisa Francesca Linda Licitra, Marta Maddalo, Almalina Bacigalupo, Liliana Belgioia, Jon Cacicedo, Nadia Facchinetti, Almudena Garcia Castano, Marc Oliva, Pierluigi Bonomo, Giuseppe Sanguineti, Pierfrancesco Franco, Athanassios Argiris, Amanda Psyrri, Ester Orlandi   +16 more
wiley   +1 more source

α-Hederin Alleviates Endoplasmic Reticulum Stress by Upregulating TRIM38 Expression, Thereby Inhibiting Hepatic Stellate Cell Activation and Liver Fibrosis. [PDF]

Biomedicines
Xu W, Yang Y, Li F, Li C, Tang G, Zhang B, Cheng M.   +6 more
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Hepatic Stellate Cell-derived IL-11 Exacerbates Liver Fibrosis via Interplay between HSCs and Macrophages. [PDF]

Int J Biol Sci
Zhang Y, He F, Lei M, Fan W, Liu X, Tao Y, Wang W, Wang B, Gong L, Chen J.   +9 more
europepmc   +1 more source

Targeting SPHK1 by 8-HETrE attenuates MASH-Driven fibrosis via restoration of hepatic stellate cell mitochondrial dynamics. [PDF]

Cell Biol Toxicol
Chen S, Li J, Xu K, Wen J, Zhang F, Zhuge Y, Wang L, Yi Y, Zhang H, Zhang W.   +9 more
europepmc   +1 more source

Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction-Associated Steatohepatitis. [PDF]

Gastroenterology
Kisseleva T, Ganguly S, Murad R, Wang A, Brenner DA.   +4 more
europepmc   +1 more source

H3K9 acetylation-dependent CHAC1 transcription in dihydroartemisinin-induced hepatic stellate cell ferroptosis. [PDF]

Chin Med J (Engl)
Shen M, Han W, Cai L, Gong W, Qian L.
europepmc   +1 more source

Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives. [PDF]

ADMET DMPK
Singh A, Akhtar A, Shukla P.
europepmc   +1 more source

Cathepsin K Alleviates Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway and Inducing Hepatic Stellate Cell Apoptosis. [PDF]

J Clin Transl Hepatol
Lin Z, Shi Y, Sun M, Cui J, Zhao D, Mao Y, Zhang C, Zhang Y, Zheng Q, Chen Y, Li S, Nan Y.   +11 more
europepmc   +1 more source

From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000-2025). [PDF]

Front Pharmacol
Mao X, Chen P, Wubur P, Liu Y, Zhao Y, Zhang S, Guan N, Li B.   +7 more
europepmc   +1 more source